Search

Search Results

• 

  Predictors of poor outcomes in juvenile dermatomyositis: what do we know? A narrative review

  Ana Martins, Sara Ganhão, Francisca Aguiar, Mariana Rodrigues, Iva Brito

  11-11-2024

  https://doi.org/10.4081/reumatismo.2024.1640

  2192

  PDF: 1041

• CO:11:3 | Belimumab for lupus nephritis patients with poor kidney function: a post-hoc analysis of the bliss-ln trial Giacomo Emmi^1|2, Ersilia Lucenteforte³, Giorgio Limoncella³, Emanuele Chiara^1|2, Marta Calatroni^4|5, Gabriella Moroni^4|5 | ¹Clinical Medicine and Rheumatology Unit, Cattinara University Hospital, Trieste, Italy; ²Department of Medical, Surgical and Health Sciences, University of Trieste, Trieste, Italy; ³Department of Statistics, Informatics and Applications Giuseppe Parenti, University of Florence, Florence, Italy; ⁴Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy; ⁵Nephrology and Dialysis Division, IRCCS Humanitas Research Hospital, Milan, Italy

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2278

  47

• Adherence to treatment of osteoporosis: an open question

  M. Varenna, L. Sinigaglia

  4-9

  https://doi.org/10.4081/reumatismo.2009.4

  1579

  PDF: 1065
• 

  Manual therapy and therapeutic exercise in the treatment of osteoarthritis of the hip: a systematic review

  A. Romeo, S. Parazza, M. Boschi, T. Nava, C. Vanti

  63-74

  27-05-2013

  https://doi.org/10.4081/reumatismo.2013.63

  7975

  PDF: 4198

• PO:08:119 | Infusional Advantage: Rituximab’s Role in Enhancing Adherence in Multimorbid Rheumatoid Arthritis Marco Capodiferro¹, Daniele Domanico¹, Angelica Napoletano¹, Giulia Righetti², Patrizia Suppressa², Vincenzo Venerito¹, Giuseppe Lopalco¹, Florenzo Iannone¹, Fabio Cacciapaglia^1|2 | ¹Rheumatology Unit, Department of Precision and Regenerative Medicine and Jonian Area DiMePRe-J University of Bari, Italy; ²Department of Medicine and Surgery, Miulli General Hospital Acquaviva delle Fonti - LUM University Casamassima Bari Acquaviva delle Fonti, Bari, Italy

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2307

  40
• 

  B cell autoimmunity and bone damage in rheumatoid arthritis

  S. Bugatti, L. Bogliolo, C. Montecucco, A. Manzo

  117-125

  16-12-2016

  https://doi.org/10.4081/reumatismo.2016.914

  3925

  PDF: 2220

• Long term functional outcome of idiopathic inflammatory myopathies

  R. Neri, M. Mosca, T. Grazzini, A. Tavoni, G. Pasero, S. Bombardieri

  40-45

  https://doi.org/10.4081/reumatismo.2001.40

  1240

  PDF: 1167

• PO:30:153 | Long-term outcomes of JIA-associated uveitis: a systematic review and meta-analysis Laura Scagnellato¹, Giacomo Cozzi¹, Matteo Molfese¹, Mariagrazia Lorenzin¹, Jamie Alexander King¹, Gianluca Poncina¹, Stefano Rizzetto¹, Roberta Ramonda¹ | ¹UOC Reumatologia, Dipartimento di Medicina dei Sistemi DIMED, Ospedale Università di Padova, Italy

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2363

  108

• Evidences of safety and tolerability of the zoledronic acid 5 mg yearly in the post-menopausal osteoporosis: the HORIZON project

  L. Dalle Carbonare, F. Bertoldo, V. Lo Cascio

  54-64

  https://doi.org/10.4081/reumatismo.2009.54

  1468

  PDF: 1159

• PO:30:157 | Radiographic assessment of measurable osteoarticular damage in juvenile idiopathic arthritis (JIA) patients transitioning to adult care Serena Pastore⁴, Marta Klanmjsceck³, Andrea Guiotto¹, Laura De Nardi^5|6, Alessia Pin⁴, Lorenzo Cereser^1|2, Andrea Taddio^3|4, Luisa Occhipinti¹, Luca Quartuccio^1|2, Alberto Tommasini^3|4, Alen Zabotti² | ¹Università degli Studi di Udine Udine, Italy; ²Ospedale Santa Maria della Misericordia Udine, Italy; ³Università degli Studi di Trieste Trieste, Italy; ⁴IRCCS Materno Infantile Burlo Garofolo Trieste, Italy; ⁵Università Tor Vergata Roma, Italy; ⁶Ospedale Pediatrico Bambino Gesù Roma, Italy

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2365

  79

• CO:07:5 | Enhanced fibroblast signatures in females with early rheumatoid arthritis highlights a potential basis for poorer treatment outcomes Benedetta Monosi¹, James Perera², Alessandra Nerviani^2|3, Maria Sole Chimenti¹, Felice Rivellese^2|3, Costantino Pitzalis^2|3|4. | ¹Rheumatology, Allergology and Clinical Immunology, Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy; ²Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Queen Mary University of London, London, UK; ³Barts Health NHS Trust and Barts Biomedical Research Centre, National Institute for Health and Care Research, London, UK; ⁴Department of Biomedical Sciences Humanitas University and IRCCS Humanitas Research Hospital, Milano, Italy

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.1980

  3864